HALL LAURIE J TRUSTEE - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 145 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2021. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
HALL LAURIE J TRUSTEE ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q4 2022$1
-99.9%
1350.0%0.00%
Q3 2022$1,0000.0%135
-32.5%
0.00%
Q2 2022$1,0000.0%2000.0%0.00%
Q1 2022$1,0000.0%2000.0%0.00%
Q4 2021$1,000
-50.0%
2000.0%0.00%
-100.0%
Q3 2021$2,000
-71.4%
200
-37.5%
0.00%
-66.7%
Q2 2021$7,000
-22.2%
3200.0%0.00%0.0%
Q1 2021$9,000
+12.5%
3200.0%0.00%0.0%
Q4 2020$8,0000.0%320
+45.5%
0.00%
-25.0%
Q3 2020$8,000
-20.0%
220
+29.4%
0.00%
-20.0%
Q4 2019$10,000
+150.0%
170
+70.0%
0.01%
+150.0%
Q3 2019$4,000
+33.3%
100
+42.9%
0.00%0.0%
Q2 2019$3,0000.0%700.0%0.00%0.0%
Q1 2019$3,0000.0%700.0%0.00%0.0%
Q4 2018$3,000
-25.0%
70
-12.5%
0.00%0.0%
Q3 2018$4,000
+33.3%
800.0%0.00%0.0%
Q2 2018$3,000
-78.6%
80
-57.9%
0.00%
-77.8%
Q1 2018$14,000
+7.7%
1900.0%0.01%
+28.6%
Q4 2017$13,000
-99.9%
190
-32.1%
0.01%
-22.2%
Q3 2017$14,034,000
+8.3%
2800.0%0.01%
+12.5%
Q2 2017$12,958,000
+29.7%
2800.0%0.01%
+33.3%
Q1 2017$9,988,0002800.01%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q2 2021
NameSharesValueWeighting ↓
Meditor Group Ltd 2,818,835$33,967,00011.67%
PLATINUM INVESTMENT MANAGEMENT LTD 1,713,176$20,644,0000.58%
Bellevue Group AG 4,519,164$54,455,0000.55%
Rhenman & Partners Asset Management AB 622,267$7,498,0000.53%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 47,534$573,0000.21%
WASATCH ADVISORS LP 3,274,360$39,456,0000.16%
EMC Capital Management 27,566$246,0000.14%
PDT Partners, LLC 120,828$1,456,0000.10%
Virtus ETF Advisers LLC 17,773$214,0000.09%
Pinz Capital Management, LP 15,300$184,0000.08%
View complete list of ESPERION THERAPEUTICS INC NE shareholders